Patient-reported outcomes (PROs) in NRG oncology/RTOG 0436: A phase 3 trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery Meeting Abstract
| Authors: | Kachnic, L. A.; Moughan, J.; Suntharalingam, M.; Ilson, D. H.; Konski, A. A.; Burrows, W.; Anker, C.; Bar Ad, V.; Thakrar, H. V.; Hayes, J. P.; Gore, E. M.; Kavadi, V. S.; Komaki, R. U.; Raben, A.; Giguere, J. K.; Pollock, J.; Greenberger, J. S.; Videtic, G. M.; Roof, K. S.; Bruner, D. W. |
| Abstract Title: | Patient-reported outcomes (PROs) in NRG oncology/RTOG 0436: A phase 3 trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery |
| Meeting Title: | 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 96 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2016 Sep 25-28 |
| Meeting Location: | Boston, MA |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-10-01 |
| Start Page: | S31 |
| Language: | English |
| ACCESSION: | WOS:000387655804405 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2016.06.088 |
| Notes: | Meeting Abstract: 68 -- 58th Annual Meeting of the American-Society-for-Radiation-Oncology -- SEP 25-28, 2016 -- Boston, MA -- Source: Wos |
